Related Experiment Video
Updated: Jun 21, 2025
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Innovating cancer drug discovery with refined phenotypic screens
Zhenyi Wang1, Alzbeta Hulikova1, Pawel Swietach1
1Department of Physiology, Anatomy, and Genetics, University of Oxford, Sherrington Building, Parks Road, Oxford OX1 3PT, UK.
Abstract:
Before molecular pathways in cancer were known to a depth that could predict targets, drug development relied on phenotypic screening, where the effectiveness of candidate chemicals is judged from functional readouts without considering the mechanisms of action. The unraveling of tumor-specific pathways has brought targets for molecularly driven drug discovery, but precedents in the field have shown that awareness of pathways does not necessarily predict therapeutic efficacy, and many cancers still lack druggable targets. Phenotypic screening therefore retains a niche in drug development where a targeted approach is not informative. We analyze the unique advantages of phenotypic screens, and how technological advances have improved their discovery power. Notable advances include the use of larger biological panels and refined protocols that address the disease-relevance and increase data content with imaging and omic approaches.
Insights
Phenotypic screening remains crucial for drug discovery when molecular targets are unknown or ineffective. Technological advances enhance its power for identifying novel cancer therapeutics.
Area of Science:
- Oncology
- Pharmacology
- Drug Discovery
Background:
- Historically, drug development relied on phenotypic screening, assessing drug efficacy via functional outcomes without mechanism insight.
- The advent of molecular pathway knowledge enabled targeted drug discovery, yet therapeutic efficacy prediction remains challenging, with many cancers lacking druggable targets.
Purpose of the Study:
- To analyze the advantages of phenotypic screening in drug discovery.
- To explore how technological advancements have improved the discovery power of phenotypic screening.
Main Methods:
- Review of phenotypic screening principles and historical context.
- Analysis of recent technological improvements in phenotypic screening, including larger biological panels and advanced data acquisition techniques.
Main Results:
- Phenotypic screening offers unique advantages, particularly when targeted approaches are insufficient.
- Technological advancements, such as integrated imaging and omics, have significantly enhanced the data content and disease relevance of phenotypic screens.
Conclusions:
- Phenotypic screening retains a vital role in drug discovery, especially for complex diseases like cancer.
- Modernized phenotypic screening platforms are powerful tools for identifying novel therapeutic candidates, addressing limitations of purely target-based approaches.
More Related Videos
Related Concept Videos
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...